Kayla Campasino
Overview
Explore the profile of Kayla Campasino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
0
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campasino K, Yourick M, Zhao Y, Sepehr E, Vaught C, Yourick J, et al.
Toxicol In Vitro
. 2024 Sep;
101:105933.
PMID: 39233107
Since the passage of the 2018 Agriculture Improvement Act (2018 Farm Bill), the number of products containing cannabis-derived compounds available to consumers have rapidly increased. Potential effects on liver function...
2.
Gao X, Campasino K, Yourick M, Zhao Y, Sepehr E, Vaught C, et al.
Toxicology
. 2024 Jul;
506:153885.
PMID: 39004335
Cannabidiol (CBD) has been reported to induce hepatotoxicity in clinical trials and research studies; however, little is known about the safety of other nonintoxicating cannabinoids. New approach methodologies (NAMs) based...
3.
Gao X, Johnson W, Yourick M, Campasino K, Sprando R, Yourick J
Regul Toxicol Pharmacol
. 2024 Jun;
151:105653.
PMID: 38825064
Despite two decades of research on silver nanoparticle (AgNP) toxicity, a safe threshold for exposure has not yet been established, albeit being critically needed for risk assessment and regulatory decision-making....
4.
Gao X, Campasino K, Yourick M, Cao Y, Yourick J, Sprando R
J Appl Toxicol
. 2024 May;
44(9):1329-1346.
PMID: 38724177
Dietary supplements containing usnic acid have been increasingly marketed for weight loss over the past decades, even though incidences of severe hepatotoxicity and acute liver failure due to their overuse...